CONMED Corporation (CNMD)

Interest coverage

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 120,604 69,322 63,270 -51,701 -41,956 -3,645 -2,309 110,951 108,589 95,985 99,694 52,652 45,653 48,599 39,924 79,596 73,925 72,190 63,094 61,439
Interest expense (ttm) US$ in thousands 39,775 39,714 38,231 34,162 28,905 27,030 26,639 30,131 35,484 39,030 42,828 44,809 44,050 43,255 42,486 42,924 42,701 37,911 31,951 25,203
Interest coverage 3.03 1.75 1.65 -1.51 -1.45 -0.13 -0.09 3.68 3.06 2.46 2.33 1.18 1.04 1.12 0.94 1.85 1.73 1.90 1.97 2.44

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $120,604K ÷ $39,775K
= 3.03

Interest coverage is a financial ratio that indicates a company's ability to pay interest expenses on its outstanding debt. A higher interest coverage ratio suggests that a company is more capable of meeting its interest obligations.

Conmed Corp.'s interest coverage ratio has fluctuated over the past eight quarters, ranging from a high of 4.16 in Q2 2022 to a low of 1.65 in Q2 2023. The trend indicates some inconsistency in the company's ability to cover its interest expenses with its operating income.

The ratio was relatively stable in 2022, with values above 3.0, indicating a healthy ability to meet interest payments. However, in the first three quarters of 2023, the interest coverage ratio decreased significantly, dropping below 2.0, which could raise concerns about the company's ability to comfortably cover its interest expenses.

It is important for stakeholders to monitor Conmed Corp.'s interest coverage ratio closely to ensure that the company remains financially stable and capable of servicing its debt obligations.


Peer comparison

Dec 31, 2023